Effectiveness of Subepithelial Connective Tissue Graft as an Autogenous Barrier Membrane for Hard and Soft Tissue Augmentation in Horizontally Deficient Ridges During Delayed Implant Placement

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorCairo University

About this trial

This study evaluates the clinical effectiveness of using a patient's own subepithelial connective tissue graft as a natural barrier membrane during simultaneous hard and soft tissue augmentation in areas of the jawbone with insufficient horizontal width. The procedure will be performed during delayed dental implant placement. The study aims to assess changes in hard and soft tissue dimensions and the clinical outcomes of this approach in patients with horizontally deficient alveolar ridges.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Presence of a single missing tooth with both neighboring teeth present

Patients at least 18 years of age

Good oral hygiene defined as full-mouth plaque score ≤25% (O'Leary, Drake, & Naylor, 1972)

Seibert class I defect at the single tooth gap as clinically assessed with buccopalatal bone dimension of at least 4 mm.

Disqualifiers

Pathological lesions (abscess-cyst-acute infection) in the defect site

Systemic diseases that would interfere with bone metabolism

Uncontrolled diabetic patients

Ongoing treatment or a history of recent chemotherapy or radiotherapy

Trial design

Design model

Single group

Treatments tested in this trial

  • Subepithelial Connective Tissue Graft as an Autogenous Barrier Membrane for Hard and Soft Tissue Augmentation in Horizontally Deficient Ridges during delayed implant placement

    Procedure/Surgery

    after local anesthetic injection, patient received intrasulcular incision, intrasulcular incisions and vertical release incisions, full-thickness flap elevation was performed, autogenous bone collection was done from implant site then the implant placed; SCTG was harvested and placed as an autogenous barrier membrane over double layer of bone graft autogenous then Xeno graft followed by suturing

Treatment groups

10 Participants
are divided into 1 treatment group
Group A: Connective Tissue Graft as an Autogenous Barrier Membrane for Hard and Soft Tissue AugmentationExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Horizontal bone gain

Change in horizontal alveolar bone width from baseline to 6 months after implant placement, measured in millimeters (mm) using standardized radiographic assessment.

Time frame
Baseline and 6 months after implant placement

Secondary outcomes

1

change in buccal and crestal soft tissue thickness

Change in buccal and crestal soft tissue thickness at the implant site from baseline to 6 months after implant placement, measured in millimeters (mm).

Time frame
baseline and 6 months after implant placement

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: